参考文献/References:
[1] 苏镜, 张雪芳, 赵清, 等.ABCG2 和BCAS3 基因mRNA 在痛风性关节炎患者中的表达水平及辅助诊断价值[J]. 热带医学杂志,2021,21(3):324-329.SU Jing,ZHANG Xuefang,ZHAO Qing,et al. Expressionof ABCG2 and BCAS3 mRNA in patients with primarygouty arthritis and its auxiliary diagnostic value[J]. Journal of Tropical Medicine,2021,21(3):324-329.
[2] RAGAB G, ELSHAHALY M, BARDIN T. Gout: anold disease in new perspective - A review[J]. Journal ofAdvanced Research, 2017, 8(5, SI): 495-511.
[3] 柳涛红, 朱丹, 青玉凤, 等. 微RNA-146a 通过Toll 样受体信号途径在RAW264.7 细胞痛风性关节炎模型炎症反应中的研究[J].中华风湿病学杂志,2020,24(8):522-529.LIU Taohong,ZHU Dan,QING Yufeng,et al. Expressionof miRNA-146a in the inflammatory response ofRAW264.7 cell through Toll-like receptor signalingpathway in gout arthritis model [J]. Chinese Journal ofRheumatology,2020,24(8):522-529.
[4] 石娇, 吴东明, 李静, 等. 痛风性关节炎中IL-1β/Caspase-1 介导的细胞焦亡的作用研究[J]. 成都医学院学报,2020,15(1):19-22.SHI Jiao,WU Dongming,LI Jing,et al. Study on theeffect of pyroptosis mediated by IL-1β/Caspase-1in gouty arthritis [J].Journal of Chengdu MedicalCollege,2020,15(1):19-22.
[5] 曹建梅.77 例痛风患者血清IL-1β 水平的变化研究与骶髂关节影像学改变分析[D]. 太原:山西医科大学,2016.CAO Jianmei.Researching the IL - 1 beta expressiondifferences in the lever of serum and analysising thecharacteristics of sacroiliac joints imaging about77 patients with gout[D].Taiyuan:Shanxi MedicalUniversity,2016.
[6] 张蓓, 玛依娜? 卡哈尔, 李瑞, 等.痛风患者发病危险因素及IL-1β 基因启动子区rs2853550 位点多态性分析[J].山东医药,2020,60(36):12-15.ZHANG Bei,MAYINA·Kahaer,LI Rui,et al. Riskfactors of gout patients and rs2853550 polymorphismin the promoter region of IL-1 β gene [J]. ShandongMedical Journal,2020,60(36):12-15.
[7] 中华医学会内分泌学分会. 中国高尿酸血症与痛风诊疗指南(2019) [J]. 中华内分泌代谢杂志,2020, 36(1):1-13.Chinese Society of Endocrinology,Chinese MedicalAssociation. Guideline for the diagnosis and managementof hyperuricemia and gout in China(2019)[J]. Chinese Journal of Endocrinology and Metabolism,2020,36(1):1-13.
[8] 谢敏, 范晓利, 赵一璟, 等.TRAF-6,IRAK-1 和NALP3 炎症因子失调在痛风性关节炎患者体内的作用研究[J]. 海南医学院学报,2020,26(12):925-931,937.XIE Min,FAN Xiaoli,ZHAO Yijing,et al. Studyon the effect of the imbalance of TRAF-6 ,IRAK-1 and NALP3 inflammatory factors in patientswith gouty arthritis [J]. Journal of Hainan MedicalUniversity,2020,26(12):925-931,937.
[9] 张志明, 齐张旸, 徐丛荣, 等.NLRP3,PYCARD,CASP1 在痛风性关节炎患者中的变化特点及其临床意义[J]. 中国免疫学杂志,2019,35(23):2895-2898,2903.ZHANG Zhiming,QI Zhangyang,XU Congrong,et al.Changes of NLRP3 , PYCARD and CASP1 in patientswith GA and its clinical significance [J].Chinese Journalof Immunology,2019,35(23):2895-2898, 2903.
[10] DRELON P, GILLET P, MULLER N, et al. Pro-and antiinflammatoryproperties of human recombinant IL-1 betaduring experimental arthritis in rats:2.Period dependenteffect[J]. Life Sciences, 2018, 53(22): 1709-1717.
[11] 赖爱云,徐健,陶丽.肿瘤坏死因子-α 在痛风性关节炎患者炎症反应中的作用[J]. 中国临床研究,2018, 31 (9):1165-1169.LAI Aiyun,XU Jian,TAO Li. Tumor necrosisfactor-α in the inflammatory reaction of patientswith gouty arthritis [J].Chinese Journal of ClinicalResearch,2018,31(9):1165-1169.
[12] 赖娜, 庞雅玲, 王养维. 高尿酸血症与多系统疾病关系的研究进展[J].现代检验医学杂志,2021,36(1):151-155,160.LAI Na,PANG Yaling,WANG Yangwei. Researchprogress on the relationship between hyperuricemia andmultisystem diseases [J]. Journal of Modern LaboratoryMedicine,2021,36(1):151-155,160.
[13] 李莉, 杨天德, 徐梓辉, 等. 急性痛风性关节炎患者血清hs-CRP 水平和关节红外热像改变与疼痛程度的关系[J]. 检验医学与临床,2018,15(20):3043-3045.LI Li,YANG Tiande,XU Zihui,et al. Relationshipbetween serum hs-CRP with articular infrared thermalimaging change and pain degree in patients withacute gouty arthritis [J]. Laboratory Medicine andClinic,2018,15(20):3043-3045.
[14] 范宏涛, 张虹, 宁雪梅, 等.痛风性关节炎患者UA水平与炎性指标的相关性[J].现代医学与健康研究:(电子版),2020,4(22):1-4.FAN Hongtao,ZHANG Hong,NING Xuemei,et al.Correlation between UA levels and inflammatoryindexes in patients with gouty arthritis [J]. ModernMedicine and Health Research (Electronic version),2020,4(22):1-4.
[15] 杨西超, 郑朝晖, 牛敏, 等. 痛风性关节炎患者血清白细胞介素-1β、肿瘤坏死因子-α 和环氧化酶-2水平变化及临床意义[J]. 新乡医学院学报, 2019, 36(8):752-754.YANG Xichao,ZHENG Zhaohui,NIU Min,et al.Changes and clinical significance of the levels of seruminterleukin-1β,tumor necrosis factor-α and cyclooxygenase-2 in patients with gouty arthritis [J]. Journal ofXinxiang Medical University,2019,36(8):752-754.
[16] YOKOSE K, SATO S, ASANO T, et al. TNF-α potentiatesuric acid-induced interleukin-1β (IL-1β) secretionin human neutrophils[J]. Modern Rheumatology,2018, 28(3): 513-517.
[17] 王国庆, 邹延峰. 高尿酸血症及痛风易感基因研究进展[J]. 安徽医药,2019,23(7):1280-1285.WANG Guoqing,ZOU Ya n f e n g . R e s e a r c hprogress on hyperuricemia and gout susceptibilitygenes J]. Anhui Medical and PharmaceuticalJournal,2019,23(7):1280-1285.
[18] 李东云,冮顺奎,李捷,等.ABCG2,SLC2A9,SLC17A3和PRKG2 基因单核苷酸位点多态性与哈尼族人群痛风的关系[J].昆明医科大学学报,2021,42(3):54-60.LI Dongyun,GANG Shunkui,LI Jie,et al. Association ofABCG2, SLC2A9, SLC17A3 and PRKG2 SNPs variantswith gout in the Hani population in China [J]. Journalof Kunming Medical University,2021,42(3):54-60.
[19] 郭小梅.IL-22 及LRRC16A 基因单核苷酸多态性与痛风性关节炎的关系研究[D]. 广州: 暨南大学,2020.GUO Xiaomei.The study of the relationship of IL-22 and LRRC16A single nucleotide polymorphism ingouty arthritis[D].Guangzhou:Jinan University,2020.